The problem of complicated skin and skin structure infections: the need for new agents

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection

(2010) G. Ralph Corey et al.   CLINICAL INFECTIOUS DISEASES

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

(2010) M. H. Wilcox et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

(2010) G. R. Corey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study

(2010) R. N. Jones et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity

(2010) D. Biek et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity

(2010) G. L. Drusano   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

(2010) M. L. Corrado   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Modeling the Invasion of Community‐Acquired Methicillin‐ResistantStaphylococcus aureusinto Hospitals

(2009) Erica M. C. D’Agata et al.   CLINICAL INFECTIOUS DISEASES

Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom

(2009) F. K. Gould et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States

(2008) Y. Ge et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Activities of Ceftaroline and ME1036 Tested against Clinical Strains of Community-Acquired Methicillin-Resistant Staphylococcus aureus

(2008) H. S. Sader et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐ResistantStaphylococcus aureusDisease in San Francisco, 2004–2005

(2008) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Current Treatment Options for Community‐Acquired Methicillin‐ResistantStaphylococcus aureusInfection

(2008) Robert C. Moellering et al.   CLINICAL INFECTIOUS DISEASES

Are Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Replacing Traditional Nosocomial MRSA Strains?

(2008) K. J. Popovich et al.   CLINICAL INFECTIOUS DISEASES

Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community

(2008) Dilip Nathwani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

What Is Community‐Associated Methicillin‐ResistantStaphylococcus aureus?

(2008) Michael Z. David et al.   JOURNAL OF INFECTIOUS DISEASES

A 39-Year-Old Man With a Skin Infection

(2007) Robert C. Moellering   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION